YOLFTbeta
BI

BibbInstruments AB

BIBB · ST · Healthcare / Medical Devices

0.343SEK-0.00 (-1.44%)

Price History

Full chart

Market Stats

Previous Close0.348
Open0.335
Day Range0.318 – 0.357
52-Week Range0.3596 – 3.99
Volume187.78K
Market Cap64.23M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.21
Dividend Yield0.00%
Beta1.31
50-Day Avg0.534
200-Day Avg1.19

About

BiBBInstruments AB, a medical technology company, develops and markets electrically powered endoscopic biopsy systems in the United States and Europe. The company offers EndoDrill which enables tissue sampling, with the aim of improving diagnostics in several common cancers, including those affecting the pancreas, stomach, liver, lungs, and urinary bladder. It also provides EndoDrill GI which used for endoscopic ultrasound; EndoDrill EBUS is used in the airways during endobronchial ultrasound (EBUS); and EndoDrill URO that is used with a standard cystoscope for sampling of muscle-invasive bladder cancer. The company was incorporated in 2013 and is headquartered in Lund, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Fredrik Lindblad BSc BA, M.B.A., M.Sc., MSc ME
  • Employees4
  • HeadquartersMedicon Village, Lund, Sweden, 223 81, Sweden
  • Websitehttps://www.bibbinstruments.se

Leadership

  • Mr. Fredrik Lindblad BSc BA, M.B.A., M.Sc., MSc MEChief Executive Officer · b. 1967
  • Dr. Charles Walther M.D., Ph.D.Founder, Chief Medical Officer & Director · b. 1974

Financials

Income Statement

Currency: SEK2022-12-312023-12-312024-12-312025-12-31
Total Revenue000401.00K
Cost of Revenue000336.00K
Gross Profit00065.00K
Gross Margin---16.21%
Operating Expense11.28M11.16M12.80M14.73M
Operating Income-11.28M-11.16M-12.80M-14.67M
Operating Margin----3658.35%
EBITDA-10.98M-10.62M-12.25M-13.11M
EBITDA Margin----3270.07%
Net Income-11.28M-10.97M-12.71M-14.61M
Net Income Margin----3643.39%
R&D6.81M7.00M7.74M9.16M
R&D as % of Total Revenue---2285.54%
Interest Expense0011.00K25.00K
Interest Expense % of Total Revenue---6.23%

Balance Sheet

Currency: SEK2022-12-312023-12-312024-12-312025-12-31
Total Assets34.80M33.35M33.73M40.20M
Total Liabilities3.03M2.13M5.35M2.57M
Total Equity31.77M31.22M28.38M37.63M
Cash13.45M8.76M3.38M6.17M

Cash Flow

Currency: SEK2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-9.34M-11.71M-12.99M-13.60M
Capital Expenditure5.70M3.40M5.26M4.47M
Free Cash Flow-15.03M-15.11M-18.26M-18.07M
FCF to OCF161.01%128.98%140.48%132.89%

Earnings

Report DateDec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------------------
EPS Actual-0.14-0.09-0.12-0.11-0.21-0.12-0.13-0.10-0.31-0.17-0.13-0.08-0.10-0.07-0.08-0.07-0.10-0.07-0.10-0.05-0.09-0.07-0.08-0.05-0.08-0.07-0.08-0.05-0.09-0.05-0.06-0.05-0.09-0.12-0.05
Surprise-----------------------------------
Timing-----------------------------------

Key Statistics & Ratios

Market Cap64.23M
Enterprise Value29.59M
Trailing P/E0.00
Forward P/E0.00
Price / Sales67.83
Price / Book1.00
EPS-0.21
Book Value0.403
Revenue (TTM)947.00K
Gross Profit (TTM)115.00K
EBITDA-15.87M
Profit Margin0.00%
Operating Margin-1193.86%
Return on Equity-33.25%
Return on Assets-19.87%
Shares Outstanding160.98M
Shares Float153.69M
Beta1.31
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%